
may pm et
summari compani provid medic product servic primarili area orthoped
medic surgic medsurg well neurotechnolog spine
price-to-earnings oper ep
oper competit area global
medic devic industri character rapid
technolog innov market share volatil
medical/surg suppli unit may vulner
reduct hospit capit equip spend
demand orthoped product becom
less immun econom cycl
past perform indic futur perform reli upon
analysi prepar equiti analyst
may stock trade
look sale grow
follow rise aid
growth across major busi segment
see better intern sale
knee global strength trauma
extrem instal mako robot
estim mako robot
instal end-march full
commerci releas mako total knee
arthroplasti tka earli
tka procedur vs
procedur growth appear
deceler given
level howev think like
due season
medic maker minim invas devic
treatment airway obstruct
vexim develop vertebr compress
acquir novadaq develop fluoresc
imag technolog provid surgeon
visual blood flow
expect continu make tuck-in
acquisit drive growth
see ep
believ share trade
ep slightli peer
attract valu encourag
improv orthoped sale
 europ busi like
strengthen continu roll-out
mako robotic-arm orthoped system
view medsurg see strength
sale product non-elect procedur
see opportun continu
double-digit gain emerg market
market remain significantli
under-penetrated expect continu
look acquisit opportun like
trauson orthoped manufactur china
acquir enhanc avenu
growth addit think competit
foot strong due continu weak
one primari competitor zimmer
biomet face manufactur
risk recommend target price
competit slowdown procedur
target reflect
multipl ep
estim slightli peer
jul ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corp trace origin busi found dr homer lead orthoped
surgeon inventor sever orthoped product compani signific exposur
artifici hip prosthet knee trauma product area
reconstruct product segment consist product hip knee shoulder implant
associ implant instrument trauma-rel product artifici joint made cobalt
chromium titanium alloy ceram ultra-high molecular weight polyethylen implant
patient whose natur joint damag arthriti osteoporosi diseas injuri
also sell trauma-rel product use primarili fixat fractur result sudden injuri
includ intern fixat devic nail plate screw extern fixat devic
pin wire connect bar launch accolad ii first hip stem morphometr
wedg design evolut taper wedg stem also launch getaroundkne
direct-to-consum advertis campaign convey benefit singl radiu design
triathlon knee system acquir memomet technolog develop manufactur
market product extrem hand foot indic enhanc offer trauma
medsurg product segment produc medic surgic equip compris three
busi stryker instrument sell power surgic drill saw fixat ream equip
well instrument use drill bur rasp cut bone wire pin bone
fractur prepar hip knee surfac placement artifici hip knee joint stryker
instrument dispos suction/irrig devic stryker medic produc wide varieti
specialti stretcher custom acut care specialti surgic facil launch system
next gener heavi duti surgic power tool tool use total joint procedur
hip knee replac also launch hd endoscop camera system
util advanc semi-conductor integr circuit technolog premium optic provid
clear bright imag design enhanc patient outcom addit launch power-load
cot-fasten system lift lower cot ambul therebi reduc spinal
load risk cumul trauma injuri emerg respond
neurotechnolog spine product segment form april mainli compris
spine craniomaxillofaci cmf implant system intervent spine equip
neurovascular busi purchas boston scientif earli januari cmf product
includ plate screw system craniomaxillofaci surgeri repair small bone hand face
head receiv fda approv market trevo retriev next
gener clot remov technolog util proprietari stentriev technolog optim clot
integr retriev patient experienc acut ischem stroke also receiv approv
market trevo provu retriev first clot remov devic fulli visibl procedur
precis posit within clot optim clot retriev patient experienc acut ischem
stroke year also acquir surpass medic ltd surpass develop commerci
next-gener flow divers stent technolog treat brain aneurysm use uniqu mesh design
deliveri system acquisit benefit neurotechnolog product line addit
acquisit neurovascular divis acquir concentr medic inc
manufactur minim invas product treatment acut ischem stroke expand
neurotechnolog product offer also acquir orthovita inc develop orthobiolog
biosurgeri product includ synthet bone graft vertebr augment product
acquisit complement exist product offer primarili within spine product line
seek increas new product launch amid increas competit rise compar
effect research addit compani think shift resourc complianc
initi continu slow project reduc outsid contractor spend certain
other total cost world-wide company-sponsor research develop engin
activ relat develop new product improv exist product technic
support product complianc government regul protect custom
patient account annual sale
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
bullish sinc april technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
procedur inpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
 composit index year
date april health
declin composit index
fundament outlook health care
equip sub-industri next month
posit continu view mani product
categori histor recession-resist
expect continu grow growth
procedur rate area view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped steadili improv
see continu recoveri
medic devic tax requir
healthcar reform law went effect
januari temporarili suspend
januari
congress pass stopgap measur includ
suspend medic devic tax anoth
two year tax
slate becom effect januari
decemb congress pass tax cut
job act includ repeal
individu mandat compon
afford act requir
peopl health insur pay fine
effect januari believ repeal
individu mandat result fewer
insur peopl neg impact
equip sub-industri fewer insur
patient would like lead fewer procedur
anticip hospit
largest buyer medic equip would also
advers impact could
pressur sub-industri
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
pressur lower demand certain product
categori affect sale growth also think
 hospit becom cautiou
regard capit budget amid shift
base index
five-year market price perform may
note sector sub-industri inform base
past perform indic futur perform
reli upon
becton dickinson compani
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
acquisit rose robust growth forecast
driven rise medsurg note overal price declin
instal mako robot initi full commerci launch total knee
applic syk instal base mako system exce
anticip upgrad instal base aid sale /jeffrey loo cfa
et capit iq keep hold opinion share
stryker corpor keep target
slightli peer ep valuat also
high-end rang warrant
faster growth set ep ep vs
ahead estim sale rose broad-bas growth orthopaed
rose medsurg neurotechnolog spine organ sale
rose guid sale growth potenti advers fx
ep instal mako robot lift total
instal /jeffrey loo cfa
analyst research note compani news
corpor rais target
slightli peer next-twelve-month ep estim
ep vs higher estim rais
ep reduc ep
sale increas organ billion organ
revenu grew orthopaed segment medsurg
neurotechnolog spine given stronger-than-expect quarter see
organ annual sale grow stronger averag
growth expect medic technolog industri view posit
syk competit posit opportun gain market share
given weak competitor inc
busi due manufactur complianc issu prevent
buy hold rais target price
above-p ep estim set
ep vs ahead view sale
rose organ growth orthopaed sale rose medsurg rose
neurotechnolog rose product return market
expect slowli regain market share throughout
encourag continu improv mako robot sale see
double-digit sale growth result continu robust procedur
et cfra keep hold opinion share corpor
rais target in-lin
peer forward ep estim ep vs
ahead view rais ep estim
sale rose orthopaed medsurg neurotech
yet note growth partial off-set lower price result also
impact voluntari recal certain oral product
encourag result spite product recal hurrican impact
sold mako robot bring instal base robot /jeffrey
et cfra maintain hold opinion share corp
keep target in-lin peer
forward ep estim trim
ep estim report
voluntari product recal involv specif lot oral solut
manufactur third-parti supplier recal initi
due potenti cross-contamin oral solut manufactur
equip share non-pharmaceut product expect resum
ship product septemb return full suppli year end
rais target in-lin peer
forward ep estim ep vs
ahead estim rais ep estim
sale rose orthopaed
medsurg neurotechnolog spine see benefit
portfolio restructur aid acquisit drive growth also
agre acquir novadaq provid fluoresc imag technolog
instal mako robot help drive knee sale /jeffrey loo
rais target peer
ep estim faster growth ep
vs ahead estim sale includ contribut
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
